Cost-effectiveness analyses: Making a pseudoscience legitimate

Journal of Health Politics, Policy and Law

Volumn 26, Issue 2, 2001, Pages 383-386

  Rennie, D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS ANALYSIS; COURT; EVIDENCE BASED MEDICINE; MEDICAL LIABILITY; MEDICAL RESEARCH; NEGLIGENCE; NOTE;

EID: 0035051530     PISSN: 03616878     EISSN: None     Source Type: Journal    
DOI: 10.1215/03616878-26-2-383     Document Type: Note

References (8)

1. Improving the quality of reporting of randomized controlled trials. The CONSORT statement
2. Manufacturing consensus, marketing truth: Guidelines for economic evaluation
3. Problems with the interpretation of pharmcoeconomic analyses
4. Avoiding bias in the conduct and reporting of cost-effectiveness research sponsored by pharmaceutical companies
5. The medical review article: State of the science
6. A nasty start for NICE
7. Pharmaco-economic analyses: Making them transparent, making them credible
8. Cost-effectiveness and cost-benefit analyses in the medical literature. Are the methods being used correctly?